Challenges of Long-Term Immunosuppression in Patients with a Malignancy

This chapter explores the difficulties in deciding whether to begin long-term immunosuppression immediately after finishing oncology treatment, with limited data available and the importance of personalized decision-making.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app